These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18745754)

  • 21. Influence of BAL on the toxicity and chemotherapeutic activity of mapharsen.
    ERCOLI N; WILSON W
    J Pharmacol Exp Ther; 1948 Feb; 92(2):121-6. PubMed ID: 18903396
    [No Abstract]   [Full Text] [Related]  

  • 22. MAPHARSEN therapy of early syphilis.
    Ther Notes; 1946 Feb; ():35-41. PubMed ID: 21013238
    [No Abstract]   [Full Text] [Related]  

  • 23. BAL (2, 3-DIMERCAPTOPROPANOL) IN THE TREATMENT OF MASSIVE OVERDOSAGE WITH MAPHARSEN.
    Armstrong CD; Fleming WJ; Thalmann WG
    Calif Med; 1948 Oct; 69(4):247-52. PubMed ID: 18731546
    [No Abstract]   [Full Text] [Related]  

  • 24. [A new type of cure by the mapharsen].
    CHIAPPONI ; DAEN
    Bull Mens Soc Med Mil Fr; 1945; 39(10):309-14. PubMed ID: 21014987
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experience with mapharsen].
    LAUSECKER H
    Wien Klin Wochenschr; 1950 Jun; 62(25):448-50. PubMed ID: 15443508
    [No Abstract]   [Full Text] [Related]  

  • 26. Mapharsen: Its Use in the Treatment of Syphilis.
    Miller HE; Epstein NN; Simpson RG
    Cal West Med; 1936 Oct; 45(4):321-4. PubMed ID: 18743825
    [No Abstract]   [Full Text] [Related]  

  • 27. The Use of Mapharsen in the Treatment of Syphilis.
    Peterson SC
    Can Med Assoc J; 1937 Feb; 36(2):172-3. PubMed ID: 20320530
    [No Abstract]   [Full Text] [Related]  

  • 28. Mapharsen in Treatment of Syphilis.
    Br Med J; 1936 Feb; 1(3918):269-70. PubMed ID: 20779722
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of recent syphilis in 5 weeks, with penicillin-mapharsen-Bismuth].
    MARIN A; BOULAIS FL
    Ann Dermatol Syphiligr (Paris); 1949; 9(1):23-34. PubMed ID: 18115995
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mapharsen treatment of syphilis].
    AKOVBIAN AA; FILATOVA AA
    Vestn Venerol Dermatol; 1948; 29(1):29-33. PubMed ID: 18887741
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the influences of mapharsen on fixed neoarsphenamine eruptions; preliminary report.
    ABE M
    Tohoku J Exp Med; 1950 May; 52(1-2):48. PubMed ID: 14776730
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experiences with the mapharsen].
    FOLDVARI F
    Dermatologica; 1949; 98(2):85-97. PubMed ID: 18131466
    [No Abstract]   [Full Text] [Related]  

  • 33. Asiatic relapsing fever; report of 134 cases treated with mapharsen.
    WOLFF BP
    Ann Intern Med; 1946 Feb; 24():203-16. PubMed ID: 21012794
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bone marrow changes in the syphilis and during the combined Mapharsen bismuth treatment].
    FLEISCHHACKER H; MICHEL H
    Klin Med Osterr Z Wiss Prakt Med; 1948 Jan; 3(2):58-65. PubMed ID: 18906742
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bone marrow changes in the syphilis and during the combined Mapharsen bismuth treatment].
    FLEISCHHACKER H; MICHEL H
    Klin Med Osterr Z Wiss Prakt Med; 1948 Jan; 3(1):1-12. PubMed ID: 18906734
    [No Abstract]   [Full Text] [Related]  

  • 36. Time relationships in the reversal by BAL of the chemotherapeutic effect of mapharsen.
    PFEIFFER CC; JENNEY EH; ROSS CA
    Fed Proc; 1947; 6(1):363. PubMed ID: 20249608
    [No Abstract]   [Full Text] [Related]  

  • 37. Concurrent treatment of experimental syphilis with fever and mapharsen.
    CARPENTER CM; BOAK RA; DORN FL
    Am J Syph Gonorrhea Vener Dis; 1947 Sep; 31(5):498-505. PubMed ID: 20262381
    [No Abstract]   [Full Text] [Related]  

  • 38. [Efficiency of syphilis treatment with mapharsen].
    IAVOROVSKAIA AD
    Vestn Venerol Dermatol; 1946; (2):41-6. PubMed ID: 20290795
    [No Abstract]   [Full Text] [Related]  

  • 39. The rapid treatment of early syphilis with the combined use of penicillin and mapharsen.
    BUNDESEN HN; CRAIG RM
    Am J Syph Gonorrhea Vener Dis; 1946 Sep; 30(5):475-9. PubMed ID: 21000090
    [No Abstract]   [Full Text] [Related]  

  • 40. A mitochondria-targeted organic arsenical accelerates mitochondrial metabolic disorder and function injury.
    Fan XY; Liu YJ; Cai YM; Wang AD; Xia YZ; Hu YJ; Jiang FL; Liu Y
    Bioorg Med Chem; 2019 Mar; 27(5):760-768. PubMed ID: 30665675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.